Apollon Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apollon Inc. - overview
Established
2021
Location
Seoul, -, South Korea
Primary Industry
Medical Devices & Equipment
About
Based in Seoul, South Korea, and founded in 2021, Apollon Inc. operates as a provider of needleless glucose monitoring devices. As of 2023, the company is headed by its CEO Aram Hong. In April 2024, Apollon Inc.
raised KRW 2. 3 billion in pre-series A funding from new investors STIC Ventures and Mirae Holdings. Returning investor KB Investment and Be High Investment also participated in the round. The company develops and manufactures needleless continuous glucose monitoring (CGM) equipment using in vivo Raman glucose peaks that measure blood sugar levels in patients.
The firm device is of smartwatch size without any needle and sensor applicator.
Current Investors
Korea Tech Incubator for Startup, Ulsan Creative Economy Innovation Center, Be High Investment
Primary Industry
Medical Devices & Equipment
Sub Industries
Monitoring Equipment
Website
www.apollon.bio
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.